REAL TIME MOLECULAR IMAGER WITH UNSURPASSED RESOLUTION
Over the last decades, Positron Emission Tomography (PET) has been firmly established as the predominant molecular imaging technique due to its unmatched sensitivity and capability to address many different metabolic processes. Ho...
Over the last decades, Positron Emission Tomography (PET) has been firmly established as the predominant molecular imaging technique due to its unmatched sensitivity and capability to address many different metabolic processes. However, there is huge room for improvement, as current clinical PET scanners are limited to spatial resolutions higher than 2.5 mm and temporal resolutions longer than 5 seconds. This hampers applications of PET for preclinical research and clinical diagnosis in small tissues or lesions and precludes real-time reconstruction of metabolic images. RETIMAGER is a proposal for a molecular imaging system with a ten-fold spatial and temporal improvement on the reconstructed image with respect to current PET devices. This will not only boost the quantitative performance, but it will enable new applications in cardiology, vascular oncology, oncology, neurology, and other areas. We will achieve this milestone by developing smart radiation detectors with non-conventional geometries that combine the advantages of both pixelated and monolithic detectors, the two dominant and seemingly incompatible technologies employed in PET scanners. Our new scanner will provide 0.25 mm pixel resolvability with time frames as short as 0.01 sec. By aggregating these blocks in a unique gantry self-adapting to the geometry of the field-of-view, RETIMAGER will achieve an unprecedented increase in sensitivity and in in vivo real-time imaging with submillimeter resolution. We will pair it with high-throughput data processing and AI tools to assess with a single tracer both perfusion and metabolism in preclinical and clinical models. In the long run, RETIMAGER’s faster, lower dose, and less invasive molecular imaging technology will become a game-changer for understanding disease processes by unveiling new accurate image-based quantitative biomarkers, taking scientific and healthcare stakeholders a step closer to personalized precision medicine.ver más
Seleccionando "Aceptar todas las cookies" acepta el uso de cookies para ayudarnos a brindarle una mejor experiencia de usuario y para analizar el uso del sitio web. Al hacer clic en "Ajustar tus preferencias" puede elegir qué cookies permitir. Solo las cookies esenciales son necesarias para el correcto funcionamiento de nuestro sitio web y no se pueden rechazar.
Cookie settings
Nuestro sitio web almacena cuatro tipos de cookies. En cualquier momento puede elegir qué cookies acepta y cuáles rechaza. Puede obtener más información sobre qué son las cookies y qué tipos de cookies almacenamos en nuestra Política de cookies.
Son necesarias por razones técnicas. Sin ellas, este sitio web podría no funcionar correctamente.
Son necesarias para una funcionalidad específica en el sitio web. Sin ellos, algunas características pueden estar deshabilitadas.
Nos permite analizar el uso del sitio web y mejorar la experiencia del visitante.
Nos permite personalizar su experiencia y enviarle contenido y ofertas relevantes, en este sitio web y en otros sitios web.